Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction

Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction

US Patent 6607720 · Granted Aug 19, 2003

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System and method for conversion of rotational motion into linear actuation by m2021
System and method for conversion of range distance values to physical position b2020
Using focal myocardial stimulation to distinguish supraventricular tachycardia f2015
Compositions and methods for treating or preventing anthracycline induced cardio2015
Antiinfective free intramammary veterinary composition2014
Supraventricular stimulation to control ventricular rate2013
System and method for encryption and decryption of data transferred between comp2013
Biological pacemakers including mutated hyperpolarization-activated cyclic nucle2011
Biological pacemaker compositions and systems incorporating interstitial cells o2010
Cardiac function comprising implantation of embryonic stem cell in which differe2003
Cardiac function comprising implantation of embryonic stem cell in which differe2003
Antiinfective free intramammary veterinary composition2003